Aft Pharmaceuticals (ASX:AFP) — Material Events
ASX:AFP · 5 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
AFT Pharmaceuticals Surges to Record $24.4M Operating Profit with $255M Revenue in FY26High
AFT Pharmaceuticals posts record FY26 profit, 22% revenue growth, and raises FY27 guidance
21 May 2026
·Financial Results
·90
AFT Pharmaceuticals Eyes $300M Revenue as FDA Clears Injectable Iron Phase III TrialMedium
AFT Pharmaceuticals FY26 revenue up 22%, targets $300M+ in FY27 with strong global expansion and R&D pipeline
24 June 2026
·Investor Presentation
·90
AFT Pharmaceuticals Accelerates Global Growth with 33% Revenue Surge in 1H FY26Medium
AFT Pharmaceuticals posts 33% revenue growth in 1H FY26, targets NZ$300m revenue in FY27 with global expansion and R&D progress
20 Nov 2025
·Investor Presentation
·85
AFT Pharmaceuticals Powers Ahead with 33% Revenue Surge and R&D BreakthroughsMedium
AFT Pharmaceuticals posts 33% revenue growth, positive profit, and advances R&D with key licensing deals
20 Nov 2025
·Financial Results
·85
AFT Pharmaceuticals Accelerates Growth with 33% Revenue Surge and Global ExpansionMedium
AFT Pharmaceuticals posts 33% revenue growth, returns to profit, advances global expansion and R&D
20 Nov 2025
·Interim Financial Report
·85
No articles in this tier for the last 12 months.
Market Mentions
4
- appeared in market wrap coverage
These are market wrap articles where Aft Pharmaceuticals (ASX:AFP) was mentioned. They reflect broader market coverage, not company-specific announcements.
Market Wrap - Week 26 (22 June -> 26 June) 2026
27 June 2026
Healthcare Wrap - Week 26 (22 June -> 26 June) 2026
27 June 2026
Market Wrap - Week 21 (18 May -> 22 May) 2026
23 May 2026
Healthcare Wrap - Week 21 (18 May -> 22 May) 2026
23 May 2026